PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30014643-0	2018	[The Relationship of Clinicopathology of p16 in Non-small Cell Lung Cancer and 5-nitrogen impurity-2"-deoxycytidine-nitrogen Impurity on the Influence of p16 Expression in Lung Cancer A549 Cells].	Deoxycytidine	99-115	cyclin dependent kinase inhibitor 2A	Homo sapiens	154-157	
11098088-3	2000	In the present experiments, we have studied the effects of the demethylating agent, 5-aza-2"-deoxycytidine (5-AZA/decitabine), on the expression of aberrant p16INK4A RNA transcripts and the CDK-retinoblastoma gene pathway in HCC cell lines with p16INK4A promoter hypermethylation.	Deoxycytidine	93-106	cyclin dependent kinase inhibitor 2A	Homo sapiens	157-165	
11098088-3	2000	In the present experiments, we have studied the effects of the demethylating agent, 5-aza-2"-deoxycytidine (5-AZA/decitabine), on the expression of aberrant p16INK4A RNA transcripts and the CDK-retinoblastoma gene pathway in HCC cell lines with p16INK4A promoter hypermethylation.	Deoxycytidine	93-106	cyclin dependent kinase inhibitor 2A	Homo sapiens	245-253	
30014643-1	2018	OBJECTIVE: To investigate the relationship between expression of tumor suppressor gene p16 in non-small cell lung cancer (NSCLC) tissues and clinicopathological parameters,to further study on DNA methyltransferase inhibitors 5-nitrogen impurity-2"-deoxycytidine (5-Aza-CdR) in human lung cancer cell line A549 in regulating the expression of p16.	Deoxycytidine	245-261	cyclin dependent kinase inhibitor 2A	Homo sapiens	87-90	
22738793-8	2012	In addition, stable transfection of the p16ATF induced demethylation of p16 CpG island and trimethylation of histone H3K4, and inhibited recruitment of DNA methyltransferase 1 and trimethylation of H3K9 and H3K27 in the p16 promoter in H1299 cells without 5"-aza-deoxycytidine pretreatment.	Deoxycytidine	263-276	cyclin dependent kinase inhibitor 2A	Homo sapiens	40-43